Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-08 9:54 pm Unchanged |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 4,267,564 8.800% |
0 (Unchanged) |
Filing History |
| 2021-02-08 5:00 pm Unchanged |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 3,609,796 7.400% |
0 (Unchanged) |
Filing History |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
FMR CORP | 6,545,164 14.999% |
2,486,155 (+61.25%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
BLACKROCK INC BLK |
2,895,054 6.600% |
2,895,054 (New Position) |
Filing History |
| 2020-10-07 5:08 pm Purchase |
2020-10-02 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 4,267,564 9.900% |
200,000 (+4.92%) |
Filing History |
| 2020-10-06 2:42 pm Unchanged |
2020-10-06 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 10,542,790 24.100% |
0 (Unchanged) |
Filing History |